News
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
Make money. That's every investor's goal. How each person chooses to achieve that goal makes the difference in exactly how much money they make and how long it takes to make it.
Some stocks are
Why Shares of Silk Road Medical Are Dropping Wednesday
Shares of Silk Road Medical (NASDAQ: SILK) were down more than 33% as of 12:30 p.m. on Wednesday after the Centers for Medicare & Medicaid Services (CMS) announced a proposed change that could
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
The S&P 500 is up 15% this year, and there are many stocks that have been performing much better than that. Shares of Hims & Hers Health (NYSE: HIMS) and Viking Therapeutics (NASDAQ: VKTX) have been
Valbiotis announces its roadmap and strategic priorities on the eve of key milestones for its portfolio of innovative active substances
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Should You Buy This 7.1%-Yielding Tech Stock?
High dividend yields are attractive to investors. Who doesn't want a large stream of steady income? However, there's more to it than that, as there is an underlying asset to the dividend that could
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Vertex Pharmaceuticals' (NASDAQ: VRTX) stock has climbed nearly 20% so far this year, and for good reason. The biotech company completed a regulatory submission for what may become its next
Is This a Good Sign for Novavax?
Novavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. That's a huge gain for any stock. But it's particularly impressive for Novavax. The biotech stock has been in the
Why AT&T Stock Fell 13% in the First Half of 2023
Shares of telecom giant AT&T (NYSE: T) fell 13.4% in the first half of 2023, according to data from S&P Global Market Intelligence. Over the same time span, the S&P 500 market index gained 15.9%. In
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Sitting on Cash? These 2 Stocks Are Great Buys
Amid last year's difficult market, you may not have put all of your investable money to work -- in which case, you might have cash sitting on the sidelines. This would be the perfect time to deploy
Best Dividend Stocks to Buy: AT&T vs. Deere
Fool.com contributor Parkev Tatevosian compares Deere (NYSE: DE) and AT&T (NYSE: T) to determine which is the better dividend stock for passive income investors.
*Stock prices used were the
EQS-News: Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership
Why Shares of Novavax Are Up Monday
Shares of Novavax (NASDAQ: NVAX) were up more than 24% as of 12:08 p.m. ET on Monday after the biotech company said Friday that Canada will pay $349.6 million for unused COVID-19 shots from the
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Biogen Just Reached a Big Milestone. Why Isn't the Stock Rising?
Biogen (NASDAQ: BIIB) once stood out as one of the most successful biotech companies. It's portfolio of blockbuster multiple sclerosis drugs grew revenue into the billions of dollars. But as the
3 No-Brainer Stocks You Can Buy Right Now
Some decisions are hard. Others, however, are so easy that they require much less thought.
Three Motley Fool contributors believe they've found stocks to buy that definitely fall into the latter
Why Novartis Stock Slipped on Friday
Pharmaceutical companies depend on the patent protection they receive for their goods, so it's never a good day when it is stripped away. That was the misfortune suffered by global pharmaceutical
Why Shares of CareDx Are Jumping Friday
Shares of transplant diagnostics company CareDx (NASDAQ: CDNA) were up more than 20% as of 12:20 p.m. ET on Friday after a decision by the Centers for Medicare & Medicaid Services (CMS) that could
2 Struggling Dividend Growth Stocks That Could Make You Richer
Despite lingering economic issues, the broader stock market has recovered this year. But some companies are failing to keep up for a variety of reasons. Take AbbVie (NYSE: ABBV) and Amgen (NASDAQ:
Is Regeneron Stock a Buy After a Regulatory Blow?
Biotech giant Regeneron (NASDAQ: REGN) has been an outstanding performer over the past year. And although its stock is still up by 20% in the trailing-12-month period, the company's shares recently
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is AbbVie's Dividend Yield Safe?
AbbVie (NYSE: ABBV) is a leading pharmaceutical company that rewards its shareholders with a generous dividend policy. The company has a history of increasing its dividends for more than 50 years in
Here's Why Novocure Stock Dropped 42% in June
Novocure (NASDAQ: NVCR) shares dropped after publishing the results of an important clinical trial. The headlines looked positive at first glance, but the study raised concerns that lung cancer